These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 4319133

  • 1. Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
    Jesiotr M.
    Tubercle; 1969 Mar; 50():Suppl:54-5. PubMed ID: 4319133
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E.
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G.
    Policlinico Prat; 1967 Oct 23; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov 23; 46(11):423-8. PubMed ID: 4335256
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical experience with ethambutol.
    Wilson TM.
    Antibiot Chemother; 1970 Nov 23; 16():222-9. PubMed ID: 4108890
    [No Abstract] [Full Text] [Related]

  • 8. [Advances and principles in tuberculostatic therapy].
    Bethge H.
    Internist (Berl); 1971 Aug 23; 12(8):328-31. PubMed ID: 4328130
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S.
    Jpn J Tuberc; 1967 Jul 23; 14(1):55-65. PubMed ID: 5300098
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and bacteriological results with Myambutol.
    Goldman S, Brzaković N, Muzikravić T.
    Antibiot Chemother; 1970 Jul 23; 16():239-56. PubMed ID: 4332036
    [No Abstract] [Full Text] [Related]

  • 13. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S.
    Jpn J Tuberc; 1967 Jul 23; 14(1):45-54. PubMed ID: 4295381
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M.
    Bull Int Union Tuberc; 1968 Dec 23; 41():194-200. PubMed ID: 4303863
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB.
    Antibiotiki; 1971 Feb 23; 16(2):184-8. PubMed ID: 4326728
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment with secondary antitubercular agents].
    Ovreberg K.
    Tidsskr Nor Laegeforen; 1968 May 01; 88(9):741-9. PubMed ID: 4298856
    [No Abstract] [Full Text] [Related]

  • 19. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ.
    Probl Tuberk; 1974 May 01; (10):17-9. PubMed ID: 4370967
    [No Abstract] [Full Text] [Related]

  • 20. Duration of application and change of a regimen with secondary drugs.
    Oka S, Takase Y, Kato S.
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct 01; 15(1):46-9. PubMed ID: 4308926
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.